Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

NCT06858332 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT06858332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06858332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Recruiting
Start date
April 15, 2025
Completion date
September 30, 2027
Enrollment
2,382 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease